What's Going On With APRE Stock And IMMP Stock Today?

Published Apr 08 2021 at 2:17 PM GMT
  • Aprea Therapeutics Inc (NASDAQ: APRE) shares are trading higher after the company announced that it received FDA Orphan Drug Designation for its eprenetapopt for the treatment of acute myeloid leukemia.
  • Aprea Therapeutics is a clinical-stage biopharmaceutical company focused on developing and.


  • Published Apr 8, 2021 2:17 PM GMT